Gerrit Jan Schuurhuis

Author

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

G J Schuurhuis, G. J. Schuurhuis, G.J. SCHUURHUIS, G.J. Schuurhuis, GJ Schuurhuis, Gerrit J Schuurhuis, Gerrit J. Schuurhuis, Gerrit Jan Schuurhuis, Gert J. Ossenkoppele, Schuurhuis, Gerrit J

202

Publications

9.4K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam University of Amsterdam Erasmus MC Erasmus MC - Sophia Children’s Hospital Vrije Universiteit Amsterdam

About

Gerrit Jan Schuurhuis is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, cell biology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	33	2.4K
2	Health Sciences	14	17	1.1K
3	Engineering	2	2	503
4	Biochemistry	2	2	59
5	Biomedical Engineering	1	1	327

Gerrit Jan Schuurhuis

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Molecular Minimal Residual Disease in Acute Myeloid Leukemia Mojca Jongen‐Lavrencic, Tim Grob, Diana Hanekamp, New England Journal of Medicine	2018	756
High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study Monique Terwijn, Wim L.J. van Putten, Angèle Kelder, Journal of Clinical Oncology	2013	444
The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells Anna van Rhenen, Guus A.M.S. van Dongen, Angèle Kelder, Blood	2007	424
High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival Anna van Rhenen, N Feller, Angèle Kelder, Clinical Cancer Research	2005	370
Phenotypical and Functional Characterization of Freshly Isolated Adipose Tissue-Derived Stem Cells Maikel J. Oedayrajsingh Varma, Roel G.M. Breuls, Tabitha Schouten, Stem Cells and Development Tissue EngineeringEngineeringAdult Stem CellMatrix MineralizationBiomedical Engineering	2007	327
C-Type Lectin-Like Molecule-1 Alexander B. H. Bakker, Sonja van den Oudenrijn, Arjen Q. Bakker, Cancer Research Mixed-phenotype Acute LeukemiaGlycobiologyImmunologyMolecular BiologyImmunotherapy	2004	237
Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia Monique Terwijn, Wendelien Zeijlemaker, Angèle Kelder, PLoS ONE	2014	208
CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia Wendelien Zeijlemaker, Tim Grob, Rosa Meijer, Leukemia Hematological MalignancyMedicineAcute Myeloid LeukemiaStem CellsImmunology	2018	200
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia N Feller, M.A. van der Pol, Amber van Stijn, Leukemia Hematological MalignancyOncologyImmunophenotypic Detection MethodsMedicineMixed-phenotype Acute Leukemia	2004	182
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples Jacqueline Cloos, Bianca F. Goemans, Corine J. Hess, Leukemia Prognostic InfluenceSystems BiologyEngineeringSomatic VariantGenetic Disorder	2006	176

Page 1